Belita from the USA is a retired MD, she shares her amazing LDN Story for Chronic Pain.

Jill Brook from the US is a Researcher, Nutritionist and POTS patient and advocate who shares her experience with us.

Lupus is a complicated epigenetic process of cellular interactions that happen in genetically-susceptible people who are exposed to random and unknown environmental factors that create the conditions of lupus, or auto other autoimmune diseases. She discusses four mechanisms of action in regards to lupus and the cellular abnormalities, and recommended treatments. LDN has a positive impact, decreasing the risk of epigenetic changes as it decreases the oxidative damage. It adjusts the inflammatory cascade, and it's known to have a positive impact on gene regulation, the microbiome, and the frequency and severity of infections. Case studies are presented.

Lichen planopilaris is an autoimmune-mediated disorder with scarring hair loss. Dr. Bodemer identifies the clinical signs of lichen planopilaris (LPP), describes the autoimmune pathogenesis of lichen planopilaris, talks about the three main variants, lists some of the lifestyle factors and supplements that may be helpful in treating this condition, and helps to understand the role low dose naltrexone (LDN) may play in treating LPP. As an autoimmune disease, there is increased risk of other autoimmune conditions, with thyroid being the most common. The treatment goal is to slow down the inflammation and to limit the extent of permanent damage.

Sita from the US is a Nutritionist, POTS and EDS patient who shares her health journey with us

Compounding Pharmacist Dr Erin Panian shares her LDN experience.

Treating depression in patients with autoimmune conditions a presentations for the LDN 2019 conference by Beth Livengood NMD

Pamela Smith, MD presented LDN Use in Cognitive Decline, Lyme Disease, and Hashimoto’s Thyroiditis at the LDN Research Trust 2019 Conference

Jill Brook, MA - Intermittent Fasting presentation at the LDN Research Trust 2019 Conference

Traumatic Brain Injury Presentation by Dr Sarah Zielsdorf at the LDN Research Trust Conference